CD8A and neoplasm: Indeed, the adaptive immune response involves B lymphocytes (CD20+) and T cells (CD3+), including CD4+ T-helper 1 and cytotoxic T lymphocytes (CD8+) which counteract tumor development and progression [14,15,16].